# Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH)

> **NCT05567666** · NA · UNKNOWN · sponsor: **Dean Elterman** · enrollment: 30 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** Optilume Catheter System

## Key facts

- **NCT ID:** NCT05567666
- **Lead sponsor:** Dean Elterman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05567666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05567666, "Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05567666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
